90 related articles for article (PubMed ID: 10403546)
1. Increased production of interferon-gamma by tumour infiltrating T lymphocytes in nasopharyngeal carcinoma: indicative of an activated status.
Tang KF; Chan SH; Loh KS; Chong SM; Wang D; Yeoh KH; Hu H
Cancer Lett; 1999 Jun; 140(1-2):93-8. PubMed ID: 10403546
[TBL] [Abstract][Full Text] [Related]
2. High numbers of granzyme B/CD8-positive tumour-infiltrating lymphocytes in nasopharyngeal carcinoma biopsies predict rapid fatal outcome in patients treated with curative intent.
Oudejans JJ; Harijadi H; Kummer JA; Tan IB; Bloemena E; Middeldorp JM; Bladergroen B; Dukers DF; Vos W; Meijer CJ
J Pathol; 2002 Dec; 198(4):468-75. PubMed ID: 12434416
[TBL] [Abstract][Full Text] [Related]
3. Flow cytometric analysis of tumour infiltrating lymphocyte activation and tumour cell MHC class I and II expression in breast cancer patients.
Whitford P; George WD; Campbell AM
Cancer Lett; 1992 Jan; 61(2):157-64. PubMed ID: 1730139
[TBL] [Abstract][Full Text] [Related]
4. Phenotype, cytokine production and cytolytic capacity of fresh (uncultured) tumour-infiltrating T lymphocytes in human renal cell carcinoma.
Van den Hove LE; Van Gool SW; Van Poppel H; Baert L; Coorevits L; Van Damme B; Ceuppens JL
Clin Exp Immunol; 1997 Sep; 109(3):501-9. PubMed ID: 9328129
[TBL] [Abstract][Full Text] [Related]
5. Increase in tumour-infiltrating lymphocytes with regulatory T cell immunophenotypes and reduced zeta-chain expression in nasopharyngeal carcinoma patients.
Yip WK; Abdullah MA; Yusoff SM; Seow HF
Clin Exp Immunol; 2009 Mar; 155(3):412-22. PubMed ID: 19220831
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus LMP1 status in relation to apoptosis, p53 expression and leucocyte infiltration in nasopharyngeal carcinoma.
Shao JY; Ernberg I; Biberfeld P; Heiden T; Zeng YX; Hu LF
Anticancer Res; 2004; 24(4):2309-18. PubMed ID: 15330177
[TBL] [Abstract][Full Text] [Related]
7. A distinct expression of CC chemokines by macrophages in nasopharyngeal carcinoma: implication for the intense tumor infiltration by T lymphocytes and macrophages.
Tang KF; Tan SY; Chan SH; Chong SM; Loh KS; Tan LK; Hu H
Hum Pathol; 2001 Jan; 32(1):42-9. PubMed ID: 11172294
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxic potential despite impaired activation pathways in T lymphocytes infiltrating nasopharyngeal carcinoma.
Ferradini L; Miescher S; Stoeck M; Busson P; Barras C; Cerf-Bensussan N; Lipinski M; von Fliedner V; Tursz T
Int J Cancer; 1991 Feb; 47(3):362-70. PubMed ID: 1899651
[TBL] [Abstract][Full Text] [Related]
9. Immunohistological characteristics of the infiltrating lymphoid cells and expression of HLA class I and II antigens in nasopharyngeal carcinoma.
Lai FM; Cheng PN; Tsao SY; Lai KN
Virchows Arch A Pathol Anat Histopathol; 1990; 417(4):347-52. PubMed ID: 1978435
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneity of HLA and EBER expression in Epstein-Barr virus-associated nasopharyngeal carcinoma.
Yao Y; Minter HA; Chen X; Reynolds GM; Bromley M; Arrand JR
Int J Cancer; 2000 Dec; 88(6):949-55. PubMed ID: 11093820
[TBL] [Abstract][Full Text] [Related]
11. Increased populations of regulatory T cells in peripheral blood and tumor-infiltrating lymphocytes in patients with gastric and esophageal cancers.
Ichihara F; Kono K; Takahashi A; Kawaida H; Sugai H; Fujii H
Clin Cancer Res; 2003 Oct; 9(12):4404-8. PubMed ID: 14555512
[TBL] [Abstract][Full Text] [Related]
12. Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix.
Santin AD; Ravaggi A; Bellone S; Pecorelli S; Cannon M; Parham GP; Hermonat PL
Gynecol Oncol; 2001 Jun; 81(3):424-32. PubMed ID: 11371133
[TBL] [Abstract][Full Text] [Related]
13. Intratumour T cells, their activation status and survival in gastric carcinomas characterised for microsatellite instability and Epstein-Barr virus infection.
Chiaravalli AM; Feltri M; Bertolini V; Bagnoli E; Furlan D; Cerutti R; Novario R; Capella C
Virchows Arch; 2006 Mar; 448(3):344-53. PubMed ID: 16261379
[TBL] [Abstract][Full Text] [Related]
14. Expression of immune regulatory molecules in Epstein-Barr virus-associated nasopharyngeal carcinomas with prominent lymphoid stroma. Evidence for a functional interaction between epithelial tumor cells and infiltrating lymphoid cells.
Agathanggelou A; Niedobitek G; Chen R; Nicholls J; Yin W; Young LS
Am J Pathol; 1995 Oct; 147(4):1152-60. PubMed ID: 7573360
[TBL] [Abstract][Full Text] [Related]
15. Elevated blood levels of soluble tumor necrosis factor receptors in nasopharyngeal carcinoma: correlation with humoral immune response to lytic replication of Epstein-Barr virus.
Feng P; Chan SH; Ooi EE; Soo MY; Loh KS; Wang D; Ren EC; Hu H
Int J Oncol; 1999 Jul; 15(1):167-72. PubMed ID: 10375611
[TBL] [Abstract][Full Text] [Related]
16. Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma.
Freedman RS; Kudelka AP; Kavanagh JJ; Verschraegen C; Edwards CL; Nash M; Levy L; Atkinson EN; Zhang HZ; Melichar B; Patenia R; Templin S; Scott W; Platsoucas CD
Clin Cancer Res; 2000 Jun; 6(6):2268-78. PubMed ID: 10873077
[TBL] [Abstract][Full Text] [Related]
17. Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer.
Woo EY; Chu CS; Goletz TJ; Schlienger K; Yeh H; Coukos G; Rubin SC; Kaiser LR; June CH
Cancer Res; 2001 Jun; 61(12):4766-72. PubMed ID: 11406550
[TBL] [Abstract][Full Text] [Related]
18. T cell functions of IL-2-activated tumor-infiltrating lymphocytes from renal cell carcinoma.
Morita T; Salmeron MA; Hayakawa K; Swanson DA; von Eschenbach AC; Itoh K
Reg Immunol; 1992; 4(4):225-35. PubMed ID: 1476875
[TBL] [Abstract][Full Text] [Related]
19. Structure and regulation of the blast-2/CD23 antigen in epithelial cells from nasopharyngeal carcinoma.
Rousselet G; Busson P; Billaud M; Guillon JM; Scamps C; Wakasugi H; Lenoir G; Tursz T
Int Immunol; 1990; 2(12):1159-66. PubMed ID: 2151025
[TBL] [Abstract][Full Text] [Related]
20. Presence of in vivo-activated T-cells expressing HLA-DR molecules and IL-2 receptors in peripheral blood of patients with nasopharyngeal carcinoma.
Lakhdar M; Ellouz R; Kammoun H; Ben H'Tira S; Khedhiri N; Kastally R; Fridman WH
Int J Cancer; 1987 Jun; 39(6):663-9. PubMed ID: 3034803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
